Eribulin Mesylate Injection
Product Images NDC 60505-6435

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 60505-6435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image
Novaplus Logo (Novaplus Logo)
FDA Label Image

Eribulin-spl-carton-label (Eribulin Spl Carton Label)

Eribulin-spl-carton-label (Eribulin Spl Carton Label)
FDA Label Image

Eribulin-spl-fig-1 (Eribulin Spl Fig 1)

Eribulin-spl-fig-1 (Eribulin Spl Fig 1)
FDA Label Image

Eribulin-spl-fig-2 (Eribulin Spl Fig 2)

Eribulin-spl-fig-2 (Eribulin Spl Fig 2)
FDA Label Image

Eribulin-spl-structure (Eribulin Spl Structure)

Eribulin-spl-structure (Eribulin Spl Structure)
FDA Label Image

Eribulin-spl-vial-label (Eribulin Spl Vial Label)

Eribulin-spl-vial-label (Eribulin Spl Vial Label)
This is a prescription medicine labeled as Eribulin Mesylate Injection. The National Drug Code (NDC) is 60505-6435-0. It is advised to discard any unused portion of the medication. The product is distributed under the Novaplus brand.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.